Cerus Corporation
CERS
#7172
Rank
C$0.74 B
Marketcap
C$3.70
Share price
-0.37%
Change (1 day)
99.06%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus Corporation's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.33 Million, an increase over its 2023 earnings that were of -C$39.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-37.27%
2024 -C$16.33 Million-58.95%
2023 -C$39.78 Million-20.74%
2022 -C$50.18 Million-25.7%
2021 -C$67.54 Million-11.99%
2020 -C$76.73 Million-14%
2019 -C$89.23 Million21.73%
2018 -C$73.3 Million-0.65%
2017 -C$73.78 Million-10.96%
2016 -C$82.86 Million4.24%
2015 -C$79.49 Million50.99%
2014 -C$52.65 Million-10.08%
2013 -C$58.55 Million184.13%
2012 -C$20.61 Million-7.91%
2011 -C$22.38 Million
2009 -C$31.61 Million-24.69%
2008 -C$41.97 Million-25.2%
2007 -C$56.1 Million330.54%
2006 -C$13.03 Million1.49%
2005 -C$12.84 Million-61.02%
2004 -C$32.94 Million
2002 -C$81.48 Million10.02%
2001 -C$74.06 Million34.25%
2000 -C$55.16 Million61.02%
1999 -C$34.26 Million-18.81%
1998 -C$42.2 Million93.08%
1997 -C$21.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.14 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$20.08 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.34 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.05 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA